Bing

ALL RESULTS

1-20 of 413,000 results·

  • The addition of leucovorin to XELODA is not recommended. There was no apparent advantage in response rate by adding leucovorin to XELODA; however, toxicity was increased.

    • www.xeloda.com/hcp/default.aspx
  • The addition of leucovorin to XELODA is not recommended. There was no apparent advantage in response rate by adding leucovorin to XELODA; however, toxicity was increased.

    • www.rochereimbursement.com/xeloda
  • The addition of leucovorin to XELODA is not recommended. There was no apparent advantage in response rate by adding leucovorin to XELODA; however, toxicity was increased.

    • www.medscape.com/infosite/xeloda/

  • XELODA Reimbursement The Roche Oncoline Patient Assistance Program offers assistance to patients who have no prescription coverage or have reached their cap and meet specific ...

    • www.xeloda.com/resource-center/xeloda-insurance-coverage.aspx
  • QUESTIONS? Call the Oncoline Reimbursement Hotline 1-800-443-6676 Fax: 1-866-496-8702

    • www.rochereimbursement.com/xeloda/patientassistance
  • ONCOLINE Reimbursement Hotline and Patient Assistance Program for XELODA The Roche reimbursement hotline both professionals and patients to valuable patient assistance ...

    • www.xeloda.com/hcp/reimbursement/xeloda-reimbursement.aspx

  • Billing Medicare for XELODA ... with the appropriate NDC code rather than with an HCPCS or J code. Outpatient claims for covered oral anticancer drugs such as XELODA must ...

    • www.rochereimbursement.com/xeloda/billingcoding?path=/RocheRIMSCSRepository/Xeloda/billing_coding/DMEMAC/clearinghouse.html
  • Codes of Self-Administered Drugs No Longer Covered When Obtained from Non-Retail Pharmacy ... Cabergoline, oral, 0.25 mg Dostinex J8520 Capecitabine, oral, 150mg Xeloda J8521 Capecitabine ...

    • www.bcbsla.com/web/reddotcm/files/J_Code_Non-Payable_Drug_List.pdf
  • Xeloda® (capecitabine) continued disease-free survival (DFS) comparable with 5-FU/LV with ... (Baltimore, MD - December 28, 2004) Aloxi® (palonosetron HCI) will have a new J code ...

    • https://www.iononline.com/display.aspx?cid=ArchivedNews.cms

xeloda

Capecitabine (INN) (Xeloda, Roche) is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where ...

Pagination